These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 37153758)
1. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. Rezaee M; Mohammadi F; Keshavarzmotamed A; Yahyazadeh S; Vakili O; Milasi YE; Veisi V; Dehmordi RM; Asadi S; Ghorbanhosseini SS; Rostami M; Alimohammadi M; Azadi A; Moussavi N; Asemi Z; Aminianfar A; Mirzaei H; Mafi A Front Pharmacol; 2023; 14():1152672. PubMed ID: 37153758 [TBL] [Abstract][Full Text] [Related]
2. Tumor-Derived Exosomal Non-Coding RNAs: The Emerging Mechanisms and Potential Clinical Applications in Breast Cancer. Yi Y; Wu M; Zeng H; Hu W; Zhao C; Xiong M; Lv W; Deng P; Zhang Q; Wu Y Front Oncol; 2021; 11():738945. PubMed ID: 34707990 [TBL] [Abstract][Full Text] [Related]
3. Spotlight on Exosomal Non-Coding RNAs in Breast Cancer: An In Silico Analysis to Identify Potential lncRNA/circRNA-miRNA-Target Axis. Ashekyan O; Abdallah S; Shoukari AA; Chamandi G; Choubassy H; Itani ARS; Alwan N; Nasr R Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955480 [TBL] [Abstract][Full Text] [Related]
4. The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma. Wang W; Hao LP; Song H; Chu XY; Wang R Front Oncol; 2022; 12():790916. PubMed ID: 35280805 [TBL] [Abstract][Full Text] [Related]
5. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643 [TBL] [Abstract][Full Text] [Related]
6. Exosomal Non-coding RNAs-Mediated Crosstalk in the Tumor Microenvironment. Chen Q; Li Y; Liu Y; Xu W; Zhu X Front Cell Dev Biol; 2021; 9():646864. PubMed ID: 33912560 [TBL] [Abstract][Full Text] [Related]
7. The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance. Lampropoulou DI; Pliakou E; Aravantinos G; Filippou D; Gazouli M Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163397 [TBL] [Abstract][Full Text] [Related]
8. The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer. Zhao Z; Zhao G; Yang S; Zhu S; Zhang S; Li P Cancer Cell Int; 2021 Jul; 21(1):364. PubMed ID: 34243775 [TBL] [Abstract][Full Text] [Related]
9. Drug resistance in breast cancer is based on the mechanism of exocrine non-coding RNA. Ye S; Chen S; Yang X; Lei X Discov Oncol; 2024 May; 15(1):138. PubMed ID: 38691224 [TBL] [Abstract][Full Text] [Related]
10. Insights on the Biomarker Potential of Exosomal Non-Coding RNAs in Colorectal Cancer: An In Silico Characterization of Related Exosomal lncRNA/circRNA-miRNA-Target Axis. Mezher M; Abdallah S; Ashekyan O; Shoukari AA; Choubassy H; Kurdi A; Temraz S; Nasr R Cells; 2023 Apr; 12(7):. PubMed ID: 37048155 [TBL] [Abstract][Full Text] [Related]
11. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers. Hashemipour M; Boroumand H; Mollazadeh S; Tajiknia V; Nourollahzadeh Z; Rohani Borj M; Pourghadamyari H; Rahimian N; Hamblin MR; Mirzaei H Gynecol Oncol; 2021 Apr; 161(1):314-327. PubMed ID: 33581845 [TBL] [Abstract][Full Text] [Related]
12. Exosomal circular RNAs: New player in breast cancer progression and therapeutic targets. Hussen BM; Mohamadtahr S; Abdullah SR; Hidayat HJ; Rasul MF; Hama Faraj GS; Ghafouri-Fard S; Taheri M; Khayamzadeh M; Jamali E Front Genet; 2023; 14():1126944. PubMed ID: 36926585 [TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways. Hashemi M; Roshanzamir SM; Paskeh MDA; Karimian SS; Mahdavi MS; Kheirabad SK; Naeemi S; Taheriazam A; Salimimoghaddam S; Entezari M; Mirzaei S; Samarghandian S Eur J Pharmacol; 2023 Feb; 941():175380. PubMed ID: 36627099 [TBL] [Abstract][Full Text] [Related]
14. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism. Hashem M; Mohandesi Khosroshahi E; Aliahmady M; Ghanei M; Soofi Rezaie Y; Alsadat Jafari Y; Rezaei F; Khodaparast Eskadehi R; Kia Kojoori K; Jamshidian F; Nabavi N; Rashidi M; Hasani Sadi F; Taheriazam A; Entezari M Noncoding RNA Res; 2024 Jun; 9(2):560-582. PubMed ID: 38515791 [TBL] [Abstract][Full Text] [Related]
15. Exosomal LncRNAs and CircRNAs in lung cancer: Emerging regulators and potential therapeutic targets. Li X; Wu Y; Jin Y Noncoding RNA Res; 2024 Dec; 9(4):1069-1079. PubMed ID: 39022675 [TBL] [Abstract][Full Text] [Related]
16. Emerging Function and Clinical Significance of Exosomal circRNAs in Cancer. Wang M; Yu F; Li P; Wang K Mol Ther Nucleic Acids; 2020 Sep; 21():367-383. PubMed ID: 32650235 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation in myocardial infarction: Non-coding RNAs and exosomal non-coding RNAs. Fadaei S; Zarepour F; Parvaresh M; Motamedzadeh A; Tamehri Zadeh SS; Sheida A; Shabani M; Hamblin MR; Rezaee M; Zarei M; Mirzaei H Front Cardiovasc Med; 2022; 9():1014961. PubMed ID: 36440025 [TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs and macrophage interaction in tumor progression. Entezari M; Sadrkhanloo M; Rashidi M; Asnaf SE; Taheriazam A; Hashemi M; Ashrafizadeh M; Zarrabi A; Rabiee N; Hushmandi K; Mirzaei S; Sethi G Crit Rev Oncol Hematol; 2022 May; 173():103680. PubMed ID: 35405273 [TBL] [Abstract][Full Text] [Related]
19. The role of ncRNAs and exosomes in the development and progression of endometrial cancer. Niebora J; Woźniak S; Domagała D; Data K; Farzaneh M; Zehtabi M; Dari MAG; Pour FK; Bryja A; Kulus M; Mozdziak P; Dzięgiel P; Kempisty B Front Oncol; 2024; 14():1418005. PubMed ID: 39188680 [TBL] [Abstract][Full Text] [Related]
20. Exosomal long non-coding RNAs: novel molecules in gastrointestinal cancers' progression and diagnosis. Roshani M; Baniebrahimi G; Mousavi M; Zare N; Sadeghi R; Salarinia R; Sheida A; Molavizadeh D; Sadeghi S; Moammer F; Zolfaghari MR; Mirzaei H Front Oncol; 2022; 12():1014949. PubMed ID: 36591473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]